“Therapeutics company Closed Loop Medicine, whose UK registered office is at Babraham Research Campus, is scaling fast internationally on the back of a number of key hires – including a star finance chief.

The three-year-old health technology business has persuaded Melissa Strange to join as chief financial officer from Summit Therapeutics plc where she was VP finance and, until recently, acting CFO.

She will join CLM’s leadership team alongside the four founders to support the company through its next financing and growth as well as to support commercial strategy and partnership opportunities.

Dr Hakim Yadi, CEO of Closed Loop Medicine says: “Melissa’s appointment demonstrates our commitment to building a strong leadership team. She has a fantastic background in finance as well as experience through all stages of a company’s development. I am delighted Melissa is joining us at this exciting point in our growth.”

Strange believes the company has outstanding growth prospects. She said: “CLM’s approach has the potential to fix the broken link between patients and their physicians by masterfully integrating a patient’s prescription with their real time data in order to rapidly optimise care.”